Mercapturic acids derived from the toxicants acrolein and crotonaldehyde in the urine of cigarette smokers from five ethnic groups with differing risks for lung cancer

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Park, Sungshim L ^a   Carmella, Steven G ^b   Chen, Menglan ^b   Patel, Yesha ^a   Stram, Daniel O ^a   Haiman, Christopher A ^a   Le Marchand, Loic ^c   Hecht, Stephen S ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 1 METHYLPROPYLMERCAPTURIC ACID; 3 HYDROXYPROPYLMERCAPTURIC ACID; ACETYLCYSTEINE; ACROLEIN; CREATININE; CROTONALDEHYDE; NICOTINE; UNCLASSIFIED DRUG; 2-BUTENAL; 3-HYDROXY-1-METHYLPROPYLMERCAPTURIC ACID; ALDEHYDE; S-(3-HYDROXYPROPYL)CYSTEINE N-ACETATE;

ADULT; AFRICAN AMERICAN; AGE; AGED; AMINO ACID URINE LEVEL; ARTICLE; ASIAN AMERICAN; CANCER RISK; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HISPANIC; HUMAN; LUNG CANCER; MALE; NATIVE HAWAIIAN; PHENOTYPE; SEX; SMOKING; ANALOGS AND DERIVATIVES; CHEMISTRY; ETHNIC GROUP; HAWAII; LUNG TUMOR; MIDDLE AGED; RISK FACTOR; URINE;

ACETYLCYSTEINE; ACROLEIN; AGED; ALDEHYDES; ETHNIC GROUPS; FEMALE; HAWAII; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RISK FACTORS; SMOKING;

EID: 84936850238     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124841     Document Type: Article

References (75)

1. International Agency for Research on Cancer. The Global and Regional Burden of Cancer. In: Stewart BW, Wild CP, editors. World Cancer Report 2014. Lyon, FR: International Agency for Research on Cancer; 2014. pp. 16-53.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61: 69-90. doi: 10.3322/caac.20107 PMID: 21296855
3. United States Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
4. rd Edition. Atlanta, GA: American Cancer Society and World Lung Foundation; 2009.
5. Haiman CA, Stram DO, Wilkens LR, Pike MC, Kolonel LN, Henderson BE, et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med. 2006; 354: 333-342. PMID: 16436765
6. Blot WJ, Cohen SS, Aldrich M, McLaughlin JK, Hargreaves MK, Signorello LB. Lung cancer risk among smokers of menthol cigarettes. J Natl Cancer Inst. 2011; 103: 810-816. doi: 10.1093/jnci/djr102 PMID: 21436064
7. Gadgeel SM, Severson RK, Kau Y, Graff J, Weiss LK, Kalemkerian GP. Impact of race in lung cancer: analysis of temporal trends from a surveillance, epidemiology, and end results database. CHEST. 2001; 120: 55-63. PMID: 11451816
8. Harris RE, Zang EA, Anderson JI, Wynder EL. Race and sex differences in lung cancer risk associated with cigarette smoking. Int J Epidemiol. 1993; 22: 592-599. PMID: 8225730
9. Hinds MW, Stemmermann GN, Yang HY, Kolonel LN, Lee J, Wegner E. Differences in lung cancer risk from smoking among Japanese, Chinese and Hawaiian women in Hawaii. Int J Cancer. 1981; 27: 297-302. PMID: 7287220
10. Le Marchand L, Wilkens LR, Kolonel LN. Ethnic differences in the lung cancer risk associated with smoking. Cancer Epidemiol Biomarkers Prev. 1992; 1: 103-107. PMID: 1306091
11. Schwartz AG, Swanson GM. Lung carcinoma in African Americans and whites. A population-based study in metropolitan Detroit, Michigan. Cancer. 1997; 79: 45-52. PMID: 8988725
12. Sobue T, Yamamoto S, Hara M, Sasazuki S, Sasaki S, Tsugane S. Cigarette smoking and subsequent risk of lung cancer by histologic type in middle-aged Japanese men and women: the JPHC study. Int J Cancer. 2002; 99: 245-251. PMID: 11979440
13. Stellman SD, Chen Y, Muscat JE, Djordjevic MV, Richie JP Jr, Lazarus P, et al. Lung cancer risk in white and black Americans. Ann Epidemiol. 2003; 13: 294-302. PMID: 12684197
14. Stellman SD, Takezaki T, Wang L, Chen Y, Citron ML, Djordjevic MV, et al. Smoking and lung cancer risk in American and Japanese men: An international case-control study. Cancer Epidemiol Biomarkers Prev. 2001; 10: 1193-1199. PMID: 11700268
15. Fast Stats: An interactive tool for access to SEER cancer statistics. Available: http://seer.cancer.gov/ faststats. Accessed: 2014 Sep 5.
16. Murphy SE, Park S-SL, Thompson EF, Wilkens LR, Patel Y, Stram DO, et al. Nicotine N-glucurionidation relative to N-oxidation and C-oxidation and UGT2B10 genotype in five ethnic/racial groups. Carcinogenesis. 2014; 35: 2526-2533. doi: 10.1093/carcin/bgu191 PMID: 25233931
17. Patel Y, Stram DO, Wilkens LR, Park SL, Henderson BE, Le Marchand L, et al. The contribution of common genetic variation to nicotine and cotinine glucuronidation in multiple ethnic/racial populations. Cancer Epidemiol Biomarkers Prev. 2015; 24: 119-127. doi: 10.1158/1055-9965.EPI-14-0815 PMID: 25293881
18. Park SL, Carmella SG, Ming X, Stram DO, Le Marchand L, Hecht SS. Variation in levels of the lung carcinogen NNAL and its glucuronides in the urine of cigarette smokers from five ethnic groups with differing risks for lung cancer. Cancer Epidemiol Biomarkers & Prev. 2015; 24: 561-569.
19. Hecht SS, Yuan J-M, Hatsukami DK. Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention. Chem Res Toxicol. 2010; 23: 1001-1008. doi: 10.1021/tx100056m PMID: 20408564
20. Parent RA, Paust DE, Schrimpf MK, Talaat RE, Doane RA, Caravello HE, et al. Metabolism and distribution of [2,3-14C]acrolein in Sprague-Dawley rats. II. Identification of urinary and fecal metabolites. Toxicol Sci. 1998; 43: 110-120. PMID: 9710952
21. International Agency for Research on Cancer. Dry Cleaning, Some Chlorinated Solvents and Other Industrial Chemicals. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans vol. 63. Lyon, France: IARC; 1995. pp. 337-372. PMID: 9139128
22. International Agency for Research on Cancer. Dry Cleaning, Some Chlorinated Solvents and Other Industrial Chemicals. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans vol. 63. Lyon, France: IARC; 1995. pp. 373-391. PMID: 9139128
23. Chung FL, Young R, Hecht SS. Formation of cyclic 1,N2 -propanodeoxyguanosine adducts in DNA upon reaction with acrolein or crotonaldehyde. Cancer Res. 1984; 44: 990-995. PMID: 6318992
24. Minko IG, Kozekov ID, Harris TM, Rizzo CJ, Lloyd RS, Stone MP. Chemistry and biology of DNA containing 1,N2-deoxyguanosine adducts of the alpha,beta-unsaturated aldehydes acrolein, crotonaldehyde, and 4-hydroxynonenal. Chem Res Toxicol. 2009; 22: 759-778. doi: 10.1021/tx9000489 PMID: 19397281
25. Zhang S, Villalta PW, Wang M, Hecht SS. Analysis of crotonaldehyde- and acetaldehyde-derived 1,N2 - propanodeoxyguanosine adducts in DNA from human tissues using liquid chromatography-electrsopray ionization-tandem mass spectrometry. Chem Res Toxicol. 2006; 19: 1386-1392. PMID: 17040109
26. Zhang S, Villalta PW, Wang M, Hecht SS. Detection and quantitation of acrolein-derived 1,N2 -propanodeoxyguanosine adducts in human lung by liquid chromatography-electrospray ionization-tandem mass spectrometry. Chem Res Toxicol. 2007; 20: 565-571. PMID: 17385896
27. Feng Z, Hu W, Hu Y, Tang M- S. Acrolein is a major cigarette-related lung cancer agent. Preferential binding at p53 mutational hotspots and inhibition of DNA repair. Proc Natl Acad Sci USA. 2006; 103: 15404-15409. PMID: 17030796
28. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 1999; 91: 1194-1210. PMID: 10413421
29. Kolonel LN, Henderson BE, Hankin JH, Nomura AM, Wilkens LR, Pike MC, et al. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol. 2000; 151: 346-357. PMID: 10695593
30. Carmella SG, Chen M, Zarth A, Hecht SS. High throughput liquid chromatography-tandem mass spectrometry assay for mercapturic acids of acrolein and crotonaldehyde in cigarette smokers' urine. J Chromatog B. 2013; 935: 36-40. doi: 10.1016/j.jchromb.2013.07.004 PMID: 23934173
31. Yuan Y. Multiple imputation using SAS software. J Stat Softw. 2011; 45: 1-25.
32. Delaneau O, Marchini J, Zagury JF. A linear complexity phasing method for thousands of genomes. Nat Methods. 2012; 9: 179-181. doi: 10.1038/nmeth.1785 PMID: 22138821
33. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009; 5: e1000529. doi: 10.1371/journal. pgen.1000529 PMID: 19543373
34. Hukkanen J, Jacob P III, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharmacol Rev. 2005; 57: 79-115. PMID: 15734728
35. Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol. 1998; 11: 559-603. PMID: 9625726
36. Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht SS. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res. 1988; 48: 6912-6917. PMID: 3180100
37. Balbo S, Johnson CS, Kovi RC, O'Sullivan MG, Wang M, Le CT, et al. Carcinogenicity and DNA adduct formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F-344 rats. Carcinogenesis. 2014; 35: 2798-2806. doi: 10.1093/carcin/bgu204 PMID: 25269804
38. Carmella SG, Chen M, Han S, Briggs A, Jensen J, Hatsukami DK, et al. Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers. Chem Res Toxicol. 2009; 22: 734-741. doi: 10.1021/tx800479s PMID: 19317515
39. Mascher DG, Mascher HJ, Scherer G, Schmid ER. High-performance liquid chromatographic-tandem mass spectrometric determination of 3-hydroxypropylmercapturic acid in human urine. J Chromatogr B Biomed Sci Appl. 2001; 750: 163-169. PMID: 11204217
40. Yuan JM, Butler LM, Gao YT, Murphy SE, Carmella SG, Wang R, et al. Urinary metabolites of a polycyclic aromatic hydrocarbon and volatile organic compounds in relation to lung cancer development in lifelong never smokers in the Shanghai Cohort Study. Carcinogenesis. 2014; 35: 339-345. doi: 10.1093/carcin/bgt352 PMID: 24148823
41. Yuan JM, Gao YT, Wang R, Chen M, Carmella SG, Hecht SS. Urinary levels of volatile organic carcinogen and toxicant biomarkers in relation to lung cancer development in smokers. Carcinogenesis. 2012; 33: 804-809. doi: 10.1093/carcin/bgs026 PMID: 22298640
42. Yan W, Byrd GD, Brown BG, Borgerding MF. Development and validation of a direct LC-MS-MS method to determine the acrolein metabolite 3-HPMA in urine. J Chromatogr Sci. 2010; 48: 194-199. PMID: 20223085
43. Schettgen T, Musiol A, Kraus T. Simultaneous determination of mercapturic acids derived from ethylene oxide (HEMA), propylene oxide (2-HPMA), acrolein (3-HPMA), acrylamide (AAMA) and N,Ndimethylformamide (AMCC) in human urine using liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2008; 22: 2629-2638. doi: 10.1002/rcm.3659 PMID: 18666198
44. Scherer G, Urban M, Hagedorn HW, Feng S, Kinser RD, Sarkar M, et al. Determination of two mercapturic acids related to crotonaldehyde in human urine: influence of smoking. Hum Exp Toxicol. 2007; 26: 37-47. PMID: 17334178
45. Counts ME, Hsu FS, Laffoon SW, Dwyer RW, Cox RH. Mainstream smoke constituent yields and predicting relationships from a worldwide market sample of cigarette brands: ISO smoking conditions. Regul Toxicol Pharmacol. 2004; 39: 111-134. PMID: 15041144
46. Shepperd CJ, Eldridge AC, Mariner DC, McEwan M, Errington G, Dixon M. A study to estimate and correlate cigarette smoke exposure in smokers in Germany as determined by filter analysis and biomarkers of exposure. Regul Toxicol Pharmacol. 2009; 55: 97-109. doi: 10.1016/j.yrtph.2009.06.006 PMID: 19539004
47. Roethig HJ, Munjal S, Feng S, Liang Q, Sarkar M, Walk RA, et al. Population estimates for biomarkers of exposure to cigarette smoke in adult U.S. cigarette smokers. Nicotine Tob Res. 2009; 11: 1216-1225. doi: 10.1093/ntr/ntp126 PMID: 19700523
48. Morin A, Shepperd CJ, Eldridge AC, Poirier N, Voisine R. Estimation and correlation of cigarette smoke exposure in Canadian smokers as determined by filter analysis and biomarkers of exposure. Regul Toxicol Pharmacol. 2011; 61: S3-12. doi: 10.1016/j.yrtph.2010.09.020 PMID: 20937342
49. Beauchamp RO Jr, Andjelkovich DA, Kligerman AD, Morgan KT, Heck HD. A critical review of the literature on acrolein toxicity. Crit Rev Toxicol. 1985; 14: 309-380. PMID: 3902372
50. Bastos LC, Pereira PA. Influence of heating time and metal ions on the amount of free fatty acids and formation rates of selected carbonyl compounds during the thermal oxidation of canola oil. J Agric Food Chem. 2010; 58: 12777-12783. doi: 10.1021/jf1028575 PMID: 21105653
51. Seaman VY, Bennett DH, Cahill TM. Indoor acrolein emission and decay rates resulting from domestic cooking events. Atmospheric Environment. 2009; 43: 6199-6204.
52. Stevens JF, Maier CS. Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol Nutr Food Res. 2008; 52: 7-25. doi: 10.1002/mnfr.200700412 PMID: 18203133
53. Chung FL, Chen HJC, Nath RG. Lipid peroxidation as a potential source for the formation of exocyclic DNA adducts. Carcinogenesis. 1996; 17: 2105-2111. PMID: 8895475
54. Chung FL, Nath RG, Nagao M, Nishikawa A, Zhou GD, Randerath K. Endogenous formation and significance of 1,N2 -propanodeoxyguanosine adducts. Mutat Res-Fund Mol M. 1999; 424: 71-81. PMID: 10064851
55. Sarkar P, Hayes BE. Induction of COX-2 by acrolein in rat lung epithelial cells. Mol Cell Biochem. 2007; 301: 191-199. PMID: 17318410
56. Cai J, Bhatnagar A, Pierce WM Jr. Protein modification by acrolein: formation and stability of cysteine adducts. Chem Res Toxicol. 2009; 22: 708-716. doi: 10.1021/tx800465m PMID: 19231900
57. Myers CR, Myers JM. The effects of acrolein on peroxiredoxins, thioredoxins, and thioredoxin reductase in human bronchial epithelial cells. Toxicology. 2009; 257: 95-104. doi: 10.1016/j.tox.2008.12.013 PMID: 19135121
58. Spiess PC, Deng B, Hondal RJ, Matthews DE, van der Vliet A. Proteomic profiling of acrolein adducts in human lung epithelial cells. J Proteomics. 2011; 74: 2380-2394. doi: 10.1016/j.jprot.2011.05.039 PMID: 21704744
59. Bui LC, Manaa A, Xu X, Duval R, Busi F, Dupret JM, et al. Acrolein, an α,β-unsaturated aldehyde, irreversibly inhibits the acetylation of aromatic amine xenobiotics by human arylamine N-acetyltransferase 1. Drug Metab Dispos. 2013; 41: 1300-1305. doi: 10.1124/dmd.113.052258 PMID: 23633528
60. Wang HT, Hu Y, Tong D, Huang J, Gu L, Wu XR, et al. Effect of carcinogenic acrolein on DNA repair and mutagenic susceptibility. J Biol Chem. 2012; 287: 12379-12386. doi: 10.1074/jbc.M111.329623 PMID: 22275365
61. Pan J, Awoyemi B, Xuan Z, Vohra P, Wang HT, Dyba M, et al. Detection of acrolein-derived cyclic DNA adducts in human cells by monoclonal antibodies. Chem Res Toxicol. 2012; 25: 2788-2795. doi: 10. 1021/tx3004104 PMID: 23126278
62. Yin R, Liu S, Zhao C, Lu M, Tang MS, Wang H. An ammonium bicarbonate-enhanced stable isotope dilution UHPLC-MS/MS method for sensitive and accurate quantification of acrolein-DNA adducts in human leukocytes. Anal Chem. 2013; 85: 3190-3197. doi: 10.1021/ac3034695 PMID: 23431959
63. Lee HW, Wang HT, Weng MW, Hu Y, Chen WS, Chou D, et al. Acrolein- and 4-Aminobiphenyl-DNA adducts in human bladder mucosa and tumor tissue and their mutagenicity in human urothelial cells. Oncotarget. 2014; 5: 3526-3540. PMID: 24939871
64. Zhang S, Balbo S, Wang M, Hecht SS. Analysis of acrolein-derived 1,N2 -propanodeoxyguanosine adducts in human leukocyte DNA from smokers and nonsmokers. Chem Res Toxicol. 2011; 24: 119-124. doi: 10.1021/tx100321y PMID: 21090699
65. Chung FL, Tanaka T, Hecht SS. Induction of liver tumors in F344 rats by crotonaldehyde. Cancer Res. 1986; 46: 1285-1289. PMID: 3002613
66. Chung FL, Hecht SS. Formation of cyclic 1,N2 -adducts by reaction of deoxyguanosine with α-acetoxy- N-nitrosopyrrolidine, 4-(carbethoxynitrosamino)butanal, or crotonaldehyde. Cancer Res. 1983; 43: 1230-1235. PMID: 6825094
67. Pan J, Chung FL. Formation of cyclic deoxyguanosine adducts from omega-3 and omega-6 polyunsaturated fatty acids under oxidative conditions. Chem Res Toxicol. 2002; 15: 367-372. PMID: 11896684
68. Uchida K, Kanematsu M, Sakai K, Matsuda T, Hattori N, Mizuno Y, et al. Protein-bound acrolein: potential markers for oxidative stress. Proc Natl Acad Sci U S A. 1998; 95: 4882-4887. PMID: 9560197
69. Cote F, Letourneau C, Mullard G, Voisine R. Estimation of nicotine and tar yields from human-smoked cigarettes before and after the implementation of the cigarette ignition propensity regulations in Canada. Regul Toxicol Pharmacol. 2011; 61: S51-S59. doi: 10.1016/j.yrtph.2010.03.004 PMID: 20303374
70. Hee J, Callais F, Momas I, Laurent AM, Min S, Molinier P, et al. Smokers' behaviour and exposure according to cigarette yield and smoking experience. Pharmacol Biochem Behav. 1995; 52: 195-203. PMID: 7501665
71. Melikian AA, Djordjevic MV, Hosey J, Zhang J, Chen S, Zang E, et al. Gender differences relative to smoking behavior and emissions of toxins from mainstream cigarette smoke. Nicotine Tob Res. 2007; 9: 377-387. PMID: 17365769
72. Berhane K, Mannervik B. Inactivation of the genotoxic aldehyde acrolein by human glutathione transferases of classes alpha, mu, and pi. Mol Pharmacol. 1990; 37: 251-254. PMID: 2304453
73. Berhane K, Widersten M, Engstrom A, Kozarich JW, Mannervik B. Detoxication of base propenals and other alpha, beta-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases. Proc Natl Acad Sci U S A. 1994; 91: 1480-1484. PMID: 8108434
74. Pal A, Hu X, Zimniak P, Singh SV. Catalytic efficiencies of allelic variants of human glutathione S-transferase Pi in the glutathione conjugation of alpha, beta-unsaturated aldehydes. Cancer Lett. 2000; 154: 39-43. PMID: 10799737
75. Conklin DJ, Haberzettl P, Lesgards JF, Prough RA, Srivastava S, Bhatnagar A. Increased sensitivity of glutathione S-transferase P-null mice to cyclophosphamide-induced urinary bladder toxicity. J Pharmacol Exp Ther. 2009; 331: 456-469. doi: 10.1124/jpet.109.156513 PMID: 19696094